REM behavior disorders in usually treated with

REM behavior disorders in usually treated with

• A. Medications such as Ambien, Lunesta or Sonata
• B. CPAP
• C. Medications such as benzodiazepines, Sinemet, and clonidine
• D. Medications such as Provigil, Ritalin or Dexedrine

Answer: (C)

Pharmacologic management of REM sleep behavior disorder focuses on medications that reduce REM-related motor activity and, when present, treat the underlying neurological condition. Benzodiazepines, such as clonazepam, are classic first-line agents because they potentiate GABAergic inhibition, which dampens muscle activity during REM and helps prevent dream enactment behaviors. In patients with Parkinson’s disease or other neurodegenerative conditions, addressing the underlying disorder with dopaminergic therapy like levodopa-carbidopa (Sinemet) can also lessen RBD symptoms, since its treatment can improve the neural control of movement and REM atonia. Clonidine is sometimes used as an adjunct in some regimens, though it’s not as widely established as benzodiazepines. Other classes listed—sedative-hypnotics like zolpidem, or wake-promoting stimulants like modafinil and methylphenidate/dextroamphetamine—aren’t standard treatments for REM sleep behavior disorder, and CPAP targets sleep apnea rather than RBD.

Pharmacologic management of REM sleep behavior disorder focuses on medications that reduce REM-related motor activity and, when present, treat the underlying neurological condition. Benzodiazepines, such as clonazepam, are classic first-line agents because they potentiate GABAergic inhibition, which dampens muscle activity during REM and helps prevent dream enactment behaviors. In patients with Parkinson’s disease or other neurodegenerative conditions, addressing the underlying disorder with dopaminergic therapy like levodopa-carbidopa (Sinemet) can also lessen RBD symptoms, since its treatment can improve the neural control of movement and REM atonia. Clonidine is sometimes used as an adjunct in some regimens, though it’s not as widely established as benzodiazepines.

Other classes listed—sedative-hypnotics like zolpidem, or wake-promoting stimulants like modafinil and methylphenidate/dextroamphetamine—aren’t standard treatments for REM sleep behavior disorder, and CPAP targets sleep apnea rather than RBD.